Another study showed that CASC2 is a target of miR-21 [43], which is frequently overexpressed in tumor cells [135] and takes part in proliferation, migration and invasion processes, possibly through the p53 pathway [136]; but there is no data about the direct involvement of CASC2 in this pathway. This evidence concerns the gene TP53 and neoplasm.